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KEY POINTS
 Capillary malformations are the most common type of vascular malformation.
 Most capillary malformations are non-syndromic and benign.
 Recognizing the uncommon occurrence of syndromic or high risk capillary malformations is critical.

Capillary malformations (CMs) are the most common type of vascular malformation (VM). They
are slow flow, composed of enlarged capillaries
and venules with thickened perivascular cell
coverage in skin and mucous membranes.1 They
occur in approximately 0.3% to 0.5% of the population with an equal sex distribution.1–3
While most CMs occur as isolated skin findings,
a wide range of disorders feature CMs. The clinical
presentation, systemic associations, genetic mutations, and prognosis vary greatly within and between disorders; therefore, identifying a disorder
clinically can be difficult. Genotype–phenotype
correlation aids in diagnosis and is important in
better classifying syndromic CMs.
This article provides an overview of the clinical
features, genetics, and current classifications of
CMs and associated syndromes. Additionally, it
clarifies the ambiguous nomenclature present in
the existing literature.

Clinical Characteristics
CMs are slow-flow VMs, which may appear anywhere on the body. They present at birth and
grow proportionately with the individual. Coloring
ranges from vibrant pinks to reds to purples
(Fig. 1). CMs most commonly appear on the
head and neck1–3 and may extend to the lips,
gingiva, or oral mucosa.4 On the face, CMs often
follow a dermatomal distribution respecting the
midline; in some cases, however, they can involve
neighboring dermatomes. In the early neonatal
period, distinguishing CMs from an infantile

hemangioma can be difficult; infantile hemangiomas, however, tend to darken and thicken over
days to weeks, whereas CMs exhibit little change.
In most affected individuals, CMs are isolated
and not associated with any underlying abnormalities or genetic syndromes. Nonetheless, local
complications may occur including hyperkeratosis
and soft tissue hypertrophy, especially in facial lesions. Other complications in lesions of any site
include pyogenic granuloma-like proliferations,
which may ooze and bleed (Fig. 2). Eczematous
dermatitis overlying a CM, termed the Meyerson
phenomena, can lead to pruritus (Fig. 3). Additionally, stigmatization and disfigurement may
contribute to significant morbidity in some patients. In more rare cases, CMs occur in association with genetic disorders with additional
features as discussed in this article.

Pathogenesis
An error in vascular development during embryogenesis causes CMs.4 Histopathological examination is rarely performed in CMs, and only clinically
difficult cases are biopsied. Most of the involved
vessels are located in the papillary and reticular
dermis with the number of anomalous vessels
decreasing with increasing depth.4 Lesions in a
V3 dermatome, neck, and trunk regions are more
superficial in comparison to the V2 dermatomal
area and distal extremities that have more deeply
placed vessels.4,5 This becomes clinically relevant
with regard to laser treatment.
Mutations causing CMs are usually sporadic.
Several genes have been identified with both
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Fig. 1. Various port-wine birthmarks on different skin tones. Vascular blebs can be seen in image A in an adult
patient.

isolated and syndromic lesions (see Genetics
chapter for additional details).

Nevus Simplex/salmon Patch - “angel kiss,”
“stork bite”
Nevus simplex (NS), often called salmon patch,
“angel kiss,” or “stork bite,” are common vascular

Fig. 2. CM with pyogenic granuloma-like proliferations.

lesions of childhood. They are seen in up to 82% of
newborns at birth or soon after as a pale pink to
red, ill-defined patch(es).6–8 They are often seen
on the mid-forehead, upper eyelids, philtrum,
and nape of the neck. Less common sites include
the occipital scalp, parietal scalp, and upper
back.6 The lumbosacral spine can also be affected
(Fig. 4). When lesions are extensive, the term NS
complex is used. NS complex is benign, however,
a thorough physical examination to seek out additional signs of spinal dysraphism is required as NS
with additional signs, such as an atypical pit, lipoma, aplasia cuti, sinus tract, localized hypertrichosis, or tag, may identify cases of dysraphism.8
Although NS are considered CMs by the International Society for the Study of Vascular Anomalies
(ISSVA), NS are caused by dilated capillaries
within the papillary dermis and are likely due to a
lack of autonomic regulation of local vessels in
the affected skin as opposed to being true CMs.1
The vast majority of NS over the eyelids and
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CUTANEOUS AND/OR MUCOSAL CAPILLARY
MALFORMATIONS - “PORT-WINE STAIN”

Fig. 3. CM with overlying eczematous dermatitis, also
known as the Meyerson phenomena.

forehead fade over time, whereas those located at
the nape of the neck tend to persist into adulthood
albeit without significant darkening. Additionally,
unlike true CMs, NS on the face does not follow
a dermatomal distribution and are not associated
with Sturge–Weber syndrome (SWS).
Large, persistent facial NS can be associated
with underlying syndromes such as Beckwith–
Wiedemann syndrome (BWS) and macrocephalyCM syndrome (M-CM).1,9 BWS is the most
frequent genetic overgrowth syndrome, characterized by pre and postnatal overgrowth, macrosomia, macroglossia, a persistent NS, abdominal
wall defects, neonatal hypoglycemia, and renal
anomalies. Wilms tumors and other malignancies
are also a feature, especially in early childhood.
Persistent NS is also seen in megalencephaly–
CM–polymicrogyria syndrome (MCAP), nova syndrome, odontodysplasia, M-CM, and Roberts
syndrome.1,6

Fig. 4. Nevus simplex of lumbosacral spine.

PWS or nevus flammeus, seen in 3 to 5 per 1000
live births, refers to a well-demarcated pink-red
patch.6,8 The classic presentation is a unilateral
patch with a segmental distribution and midline
demarcation, most frequently located on the
face.6,10 A bilateral distribution may also be seen.
Although most CMs are stable over time, PWS
can darken and form nodules. In 55% to 70% of
cases, progressive hypertrophy of the soft tissue
or underlying bones is observed, especially if the
CMs are located on the lip or cheek (within the
V2 distribution).8,11,12 PWS are caused by a sporadic somatic mosaic activating mutation in
GNAQ or GNA11 as well as a defective expression
of smooth muscle actin (SMA) in the pericytes.10

Capillary Malformations with Central Nervous
System and/or Ocular Anomalies – Sturge–
Weber Syndrome
SWS is a sporadic neurocutaneous syndrome that
occurs in 1/50,000 infants, characterized by a triad
of facial CMs, ipsilateral leptomeningeal angiomatosis, and glaucoma with bone and/or soft tissue
involvement (Fig. 5).6,11,13 Most of the cases are
caused by a somatic activating mutation in
GNAQ or GNA11.13,14 A relatively recent study
clarified that facial CMs are defined by embryonic
craniofacial vascular patterns of development
rather than trigeminal innervation, a long-held
notion.6,11 Infants with facial CMs at higher risk
of suffering from this syndrome are those for which

Fig. 5. A 1-month-old infant with Sturge–Weber syndrome with extensive facial, trunk, and extremity
port wine birthmark with her eye patched due to
glaucoma surgery.
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the PWS affects the frontonasal placode (forehead, hemifacial or median phenotype).13 This
frontonasal distribution is common to nearly all patients with SWS and a multidermatomal lesion
and/or bilateral distribution place a patient at
higher risk.15,16
Children with SWS are at risk for seizures,
stroke-like episodes, and cognitive delays due to
the vascular stasis and poor perfusion in the cortex
beneath the leptomeningeal CMs. Further, ipsilateral CMs can occur in the choroid plexus, leading
to glaucoma, retinal detachment, and choroidal
bleeding.11 Leptomeningeal angioma are mostly
situated over occipital and posterior parietal lobes.
Laminar cortical necrosis and calcification develop
due to stasis and ischemia of the neighboring leptomeningeal angiomatosis. Dental issues are also
common such as gum hypertrophy and overgrowth of the maxilla.2,3,17
A multidisciplinary approach including dermatology, neurology, and ophthalmology with the inclusion of additional specialists is required to
monitor and treat patients with SWS.

Diffuse Capillary Malformations with
Overgrowth
Diffuse capillary malformation with overgrowth
(DCMO) is characterized by multiple and/or extensive CMs associated with overgrowth.18,19 Overgrowth typically involves the soft tissue or bone of
an extremity and does not necessarily correlate
with the location or severity of the CMs.20 Overgrowth may affect only one extremity, ipsilateral
or contralateral to the CM, or less often, an entire
side of the body and is proportionate over time.8
The CMs in DCMO are usually reticulate, pale,
diffuse, involve multiple anatomic regions, and are
stained contiguously (Fig. 6).20 Patients with
DCMO may have prominent subcutaneous veins
and varicosities, but they do not have lymphatic

anomalies.8 DCMO may arise as a consequence
of somatic activating mutations in PIK3CA, GNAQ
and GNA11.14,21 Many patients with DCMO are
on the PIK3CA-related overgrowth spectrum
(PROS) and share several features seen in other
PROS conditions such as multiple CMs, facial
asymmetry, limb overgrowth, and hand/foot anomalies such as macrodactyly and syndactyly.19
Similar to other PROS phenotypes, the association
with Wilms tumor continues to be under investigation. A recent retrospective review of 89 patients
with DCMO did not identify any cases of Wilms tumor.20 Thus, a diagnosis of DCMO generally portends a favorable prognosis with most
complications arising from potential leg length
discrepancy and those seen with extensive PWS.

RETICULATE CAPILLARY MALFORMATIONS
Capillary Malformations of Microcephalycapillary Malformation
Microcephaly-capillary malformation syndrome
(MIC-CAP) is a rare neurologic and vascular disorder characterized by congenital and progressive
microcephaly, profound developmental delay,
intractable epilepsy, optic atrophy causing blindness, small CMs on the skin, and poor somatic
growth.6,21,22 MIC-CAP is caused by homozygous
or compound heterozygous mutations in the
STAM-binding protein gene (STAMBP). Patients
with MIC-CAP display reduced STAMBP expression, accumulation of ubiquitin-conjugated protein
aggregates, elevated apoptosis, and insensitive
activation of the RAS-MAPK and PI3K-AKTmTOR pathways.23

Capillary Malformations of Megalencephalycapillary Malformation-polymicrogyria
Patients with MCAP present with congenital or
early postnatal megalencephaly, segmental overgrowth, reticulated or confluent CMs, and polymicrogyria.2,21 Often there is a prominent midline
facial CMs and segmental reticulated CMs on the
body, with overgrowth and polydactyly or syndactyly.6 Other neurologic manifestations include ventriculomegaly and cerebellar tonsillar ectopia,
which may be complicated by hydrocephalus
and Chiari malformation, respectively.20 Neurologic involvement can manifest as developmental
delay and seizures.6 Patients should be followed
for MCAP is caused by an activating somatic mutation in the PIK3CA gene.2

Capillary Malformations of CM-AVM
Fig. 6. Image of DCMO with GNAQ mutation.

Capillary Malformations-Arteriovenous Malformation (CM-AVM) affects 1/100,000 individuals.4
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CM-AVM is characterized by CMs associated with
high-flow AVMs or arteriovenous fistulas (AVFs).
Unique to CM-AVM is that new CMs may develop
over time. CMs are usually multiple, multifocal,
small (ranging from <1 cm to 3 cm in diameter),
round to oval in shape, and pink to dull red annular
macules or papules.2,3,6,24 The pinkish macules can
exhibit a brownish hue, a perilesional whitish halo of
vasoconstriction, and hypotrichosis. The white halo
suggests vascular steal and shows high flow or a
bruit on Doppler ultrasound.1,24 These pink macules are considered to be cutaneous microAVMs.24 CMs can be present with or without
AVMs and AVFs.3 AVM/AVF occur in the skin, muscles, and bones of the face, ears, thorax, and extremities, as well as in the brain and spine.2,3 It is
essential to perform ultrasound Doppler if any
warmth or palpable thrill is noted in a vascular
lesion. Genetic counseling and magnetic resonance angiography (MRA) screening for high-flow
brain or spinal AVMs may be helpful.6 In approximately one-third of individuals with CM-AVM with
AVMs, the AVM involves the bone and soft tissue
of the leg; these patients have Parkes Weber Syndrome (PKWS) as part of CM-AVM.3,25
CM-AVM is an autosomal dominant disorder
caused by germline heterozygous inactivating mutations in the RASA1 gene (p120-rasGAP) located
on chromosome 5.3,10 A second-hit somatic mutation in endothelial cells is responsible for the complete inactivation of RASA1, which is necessary for
both skin lesions and high-flow lesions to
develop.10,25 Although the penetrance of this condition is greater than 95%, the number of CMs and
the presence of AVMs is variable among affected
family members.3,25 Mutations in the EPHB4
gene cause a similar vascular disorder to that
caused by RASA1 mutations, hence, the terms
CM-AVM1 and CM-AVM2 syndrome are designated for patients with mutations in RASA1 and
EPHB4, respectively.9

CUTIS MARMORATA TELANGIECTATICA
CONGENITA
Cutis marmorata telangiectatica congenita
(CMTC) is an uncommon, distinctive cutaneous
VM noted at or very soon after birth with an unknown cause.1,26 Violaceous, reticulated or
mottled patches resemble physiologic cutis marmorata but are persistent despite local warming
and may exhibit atrophy (Fig. 7).1,10 Lesions tend
to lighten gradually over the first few years of life.
Patches may be limited to one or several extremities or may be much more extensive but typically
demonstrate demarcation at the midline. Ulceration may occur. Affected limbs can display limb

Fig. 7. CMTC in infant.

hypoplasia although hyperplasia is also seen.
The most common associated finding is limb
asymmetry (33%-68%), requiring orthopedic surgery involvement when limb length discrepancy
becomes substantial.26 Other organ systems
may be involved (eyes, CNS, heart, and so forth)
but systemic involvement is thought to be rare
and seen only in those with very extensive skin lesions. Patients with CMTC should undergo a careful physical examination to assess for other
congenital anomalies.26 CMTC may be mistaken
for reticulate PWS and, although no gene has
been identified for CMTC, this is one reason genetic evaluation may be sought.

PHAKOMATOSIS PIGMENTOVASCULARIS
Phakomatosis pigmentovascularis (PPV) is a neurocutaneous syndrome consisting of CMs in
addition to melanocytic lesions (Fig. 8). The melanocytic lesions may be dermal melanocytosis
(Mongolian spots), nevus spilus, and/or nevus of
Ota.27 The classification system for PPV has
changed throughout the years, but more recently
a four-type scheme, created by Rudolf Happle, is
utilized.28 Type 1 PPV (phakomatosis cesio flammea) is characterized by the coexistence of
dermal melanocytosis and a nevus flammeus.
Type 2 PPV (phakomatosis spilorosea) is characterized by the association of a nevus spilus and a
pale-pink nevus. Type 3 PPV or phakomatosis
cesio marmorata is the coexistence of dermal
melanocytosis with CMTC and the last group is
unclassifiable PPVs.27,29 The pathogenesis
behind PPV is activating GNAQ/GNA11 mutations; these mutations were also detected in
ocular melanoma.30,31 This syndrome can also
be associated with other complications such as
SWS, ocular melanosis, Klippel–Trenaunay syndrome (KTS), overgrowth, leg-length discrepancy, iris mammillations, iris hamartomas,
glaucoma, epilepsy, scoliosis, and others.27
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Fig. 8. 21-year-old woman with violaceous reticulated confluent patches and slight unilateral overgrowth of left
limb compared to right.

Therefore, these patients require ophthalmology
consultation and other specialists depending on
additional features.32

TELANGIECTASIA
Hereditary Hemorrhagic Telangiectasia
Hereditary hemorrhagic telangiectasia (HHT), also
known as Osler–Rendu–Weber syndrome, is a
genetically heterogeneous, autosomal dominant
disorder with high penetrance but considerable
intrafamilial variability.2,26 Incidence is estimated at
1/8000.2,33 HHT is characterized by mucocutaneous
and visceral telangiectasias and AVMs that also
affect internal organs. Patients typically present in
the first 2 decades of life.26 Initial manifestations
include recurrent epistaxis, which can be severe,
and cutaneous or mucosal CMs that rupture and
bleed after minor trauma.2 Telangiectasias are
frequently located on the lips, oral mucosa, upper
extremities, nail beds, tongue, ears, and conjunctivae. In adulthood, telangiectasias develop in the
gastrointestinal mucosa and result in significant
bleeding in 16% of patients.2,26 HHT can frequently

be complicated by the presence of clinically significant AVMs in the lungs and brain, leading to respiratory and neurologic complications, including emboli,
stroke, migraines and seizures.13,26
Commonly mutated genes in HHT are ENG,
ACVRL1, GDF2, and SMAD4. All genes are members of the same signaling pathway (TFG-b) and
various alterations in this pathway may lead to
different variants of the disease. Mutations in
ENG gene encoding for endoglin, a receptor for
TGF-b signaling proteins, correlate with HHT
type 1. Mutations in the ACVRL1 gene encoding
for the anaplastic lymphoma receptor tyrosine kinase, correlate with HHT type 2. Mutations in
SMAD4 may result in HHT as well as the autosomal dominant cancer predisposition syndrome,
juvenile polyposis syndrome.2

CAPILLARY MALFORMATIONS ASSOCIATED
WITH OTHER ANOMALIES
Klippel Trenaunay–Weber Syndrome
KTS is traditionally defined by the triad of CMs,
venous malformation, bone and/or soft-tissue
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hypertrophy of the affected limb. Additional features may include LM or VLM, and varicose veins
with or without deep venous anomalies.1,6,20,26
KTS has likely been vastly overdiagnosed as features greatly overlap with other CMs syndromes
including DCMO. The ability to genotype patients
with VMs has improved diagnostic certainty. KTS
is caused by a somatic activating mutation in
PIK3CA, which regulates cell survival and growth
through the activation of the mTOR1-ATK
pathway.20 KTS is associated with limb overgrowth and significant arteriovenous shunting
of the involved limb.26 The findings in KTS are
classically isolated to a lower extremity, with
extension onto the lower trunk.20 The CMs are
often sharply circumscribed, geographic violaceous plaques, often with visible nodules
(lymphatic blebs), which become thicker over
time and bleed as the patient matures.1,4,26
Geographic lesions are often located on the
lateral aspect of the thigh, knee, and lower
leg.20,26 Nongeographic CMs are pink to red
and scattered over the affected limb. In patients
with nongeographic CMs, other KTS symptoms
(varicose veins and overgrowth) manifest later
in life than in patients affected with a geographic
one, whose KTS is usually obvious at birth.26
Reticulate or blotchy CMs on the extremities
can also be associated with overgrowth and
venous varicosities but are less likely to demonstrate extensive underlying LM. In KTS, progressive worsening of the venous stasis and/or
lymphedema is inevitable, and ulceration, pain,
coagulopathy, thrombosis, pulmonary emboli,
and pulmonary artery hypertension are all potential comorbidities.1

Parkes Weber Syndrome
Parkes Weber syndrome (PKWS) is a congenital
disorder caused by a mutation in RASA1, defined
by the presence of cutaneous VMs including
capillary, venous, lymphatic, and AVFs.13 Patients present with cutaneous red or pink large
patches with underlying quiescent AVMs and extremity overgrowth affecting bones and soft tissue.2 It may affect either the upper or lower
extremities, including pelvic vessels, but the
lower extremities are more often affected than
the upper extremities.2,13 PKWS is often distinguished from KTS by the presence of multiple
high-flow vascular lesions in the affected limb. A
lymphatic component may be present in some
patients and congenital VMs are common. Heart
failure due to arteriovenous shunting, as well as
ischemic pain, ulceration, and edema, may rarely
occur.34

Congenital Lipomatous Overgrowth, Vascular
Malformations, Epidermal Nevis, Spinal/
Skeletal Anomalies/Scoliosis Syndrome
Congenital lipomatous asymmetric overgrowth of
the trunk with lymphatic, capillary, venous, and
combined-type vascular malformations, epidermal
nevi, scoliosis/skeletal and spinal anomalies
(CLOVES) is a PIK3CA nonprogressive overgrowth
syndrome.6 CMs tend to show a deep purple hue
and their arrangement is usually lateralized.7 The
CMs are often geographic, however, distinctive
findings include primarily thoracic lipomatous
masses mixed with LMs, venous malformations,
AVMs of the spine, soft overgrowth of feet and/or
hands, macrodactyly of the third finger, sandal
gap deformity of the toes and/or cubital deviation
of the fingers, and a high risk of coagulopathy.
The lipomatous lesions may infiltrate the retroperitoneum, mediastinum, pleura, and paraspinal
spaces.6

Proteus Syndrome
Proteus syndrome is characterized by asymmetric
overgrowth, connective tissue nevi, epidermal
nevi, cranial hyperostosis, visceral hamartomas,
and vascular anomalies, including CMs. The
most characteristic manifestations are plantar cerebriform connective tissue nevi.13,26 Proteus syndrome is caused by a somatic activating
mutation of AKT.6 This syndrome is associated
with a high risk of pulmonary abnormalities such
as thrombosis, pulmonary embolism (the leading
cause of death in affected patients), and pulmonary cysts which may be rapidly progressive, and
lead to recurrent infections.13,26

Capillary Vascular Malformation of the Lower
Lip, Lymphatic Malformations of the Head and
Neck, Asymmetry, and Partial or Generalized
Overgrowth Syndrome
Capillary malformations of the lower lip, LM of the
face and neck, asymmetry, and partial/generalized
overgrowth (CLAPO) is a rare syndrome. CLAPO is
characterized by midline symmetric lower lip CMs
associated with facial or cervical LMs that are
sometimes accompanied by asymmetric overgrowth.35 CMs of the lower lip are present in
100% of CLAPO cases. LMs may not be evident
at birth. CLAPO may arise sporadically as a consequence of somatic activating mutations in
PIK3CA.36

SUMMARY
CMs are complex congenital slow-flow VM of
dermal capillaries and postcapillary venules. In
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most cases, a diagnosis can be made on clinical
appearance and patient history. While CMs are
often isolated skin anomalies, they are rarely associated with complex malformation syndromes,
some of which may be subtle. Identifying these
syndromes is vitally important as the clinician
can differentiate benign, innocuous CMs from
those associated with life-threatening tumors,
coagulopathies, AVMs, and more. Genotyping
can be an extremely helpful tool when needed. Imaging studies are not routinely performed on
routine CMs, but ultrasonography or magnetic
resonance may be necessary for the evaluation
of associated syndromes.7,26
Furthermore, even small, isolated CMs can be
disfiguring and a source of significant psychological stress for patients.37 The goals of treatment
(discussed in the treatment section) are aimed at
reducing skin discoloration and preventing complications such as thickening, nodularity, or
ulceration.
CMs present both a diagnostic and therapeutic
challenge to physicians. Overlapping clinical features can be observed in many cases of syndromic
CMs. The classifications presented here can aid
clinicians in better identifying CMs and provide
consistent terminology to facilitate the interdisciplinary management of the diverse vascular
anomalies.

CONFLICTS OF INTEREST
Dr. M. N. Jahnke has served as a consultant for
Sanofi Genzyme. Dr. K. Pandher and Karla Escobar do not have any financial or commercial interests to disclose. There were no funding sources for
this article.

CLINICS CARE POINTS

 PIK3CA, GNAQ and GNA11 mutations are the
most common mutations in CMs.
 Most CMs of the face (PWS) are not associated
with SWS, however, those involving the frontonasal placode and are bilateral convey the
highest risk.
 Although CMs are generally stable over time,
cutaneous complications may include darkening, thickening, vascular blebs, pyogenic
granuloma-like lesions and soft tissue
hypertrophy.
 Due to the autosomal dominant inheritence
of the RASA1 gene mutation in CM-AVM, it
is one of the more common yet worrisome
syndromes associated with CMs and

recognition is critical due to the risk of internal AVMs and AVFs.
 HHT presents with CMs and extensive telangiectasias of the skin and muscosa with risk for
GI hemorrhage and AVMs.

REFERENCES
1. Maguiness SM, Liang MG. Management of capillary
malformations. Clin Plast Surg 2011;38(1):65–73.
ska K,
2. Ustaszewski A, Janowska-G1owacka J, Wo1yn
et al. Genetic syndromes with vascular malformations - update on molecular background and diagnostics. Arch Med Sci AMS 2021;17(4):965–91.
3. Orme CM, Boyden LM, Choate KA, et al. Capillary
malformation–arteriovenous
malformation
syndrome: review of the literature, proposed diagnostic
criteria, and recommendations for management. Pediatr Dermatol 2013;30(4):409–15.
4. Garzon MC, Huang JT, Enjolras O, et al. Vascular
malformations: Part I. J Am Acad Dermatol 2007;
56(3):353–70. quiz 371-374.
5. Eubanks LE, McBurney EI. Videomicroscopy of portwine stains: correlation of location and depth of
lesion. J Am Acad Dermatol 2001;44(6):948–51.
6. McCuaig CC. Update on classification and diagnosis of vascular malformations. Curr Opin Pediatr
2017;29(4):448–54.
7. Happle R. Capillary malformations: a classification using
specific names for specific skin disorders. J Eur Acad
Dermatol Venereol JEADV 2015;29(12):2295–305.
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